Success Metrics

Clinical Success Rate

77.8%

Based on 7 completed trials

Completion Rate

78%(7/9)

Active Trials

1(8%)

Results Posted

14%(1 trials)

Terminated

2(15%)

Phase Distribution

Ph not_applicable

23%

Ph phase_1

31%

Ph early_phase_1

15%

Ph phase_2

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

2(18.2%)

Phase 1Safety & dosage

4(36.4%)

Phase 2Efficacy & side effects

1(9.1%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(7)

Terminated(2)

Other(3)

Detailed Status

Completed7

unknown3

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

77.8%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (18.2%)

Phase 14 (36.4%)

Phase 21 (9.1%)

Phase 41 (9.1%)

N/A3 (27.3%)

Trials by Status

recruiting18%

unknown323%

completed754%

terminated215%

Recent Activity

1 active trials

Showing 5 of 13

recruitingearly_phase_1

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

NCT05317455

completednot_applicable

A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain

NCT04046081

completedphase_1

Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

NCT01163487

completedearly_phase_1

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

NCT03356457

terminatedphase_1

Imaging and Biomarkers of Hypoxia in Solid Tumors

NCT01123005

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT05317455Early Phase 1

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

Recruiting

NCT04046081Not Applicable

A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain

Completed

NCT01163487Phase 1

Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

Completed

NCT03356457Early Phase 1

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

Completed

NCT01123005Phase 1

Imaging and Biomarkers of Hypoxia in Solid Tumors

Terminated

NCT01797276

Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access

Unknown

NCT02469337Phase 4

Role of Preoperative Carbohydrates Drinks, Dichloroacetate and Exercise on Postoperative Muscle Insulin Resistance

Unknown

NCT00566410Phase 1

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours

Completed

NCT01111097Phase 1

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

Completed

NCT00865514Not Applicable

Pharmacotoxicology of Trichloroethylene Metabolites

Terminated

NCT00031161Not Applicable

Prevention of Dichloroacetate Toxicity

Completed

NCT00015015

Dichloroacetate Kinetics, Metabolism and Toxicology

Completed

NCT00068913Phase 2

Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

Unknown

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13